explore -WSS

explore

author：fashion 2025-08-23 05:02:30 - browse：3168

Beth Israel Deaconess Medical Center in Boston — David L. Ryan/The Boston Globe

Steward Health Care’s Massachusetts hospitals are on the brink of financial disaster. But in many important ways, Steward’s troubles are just a symptom of a larger crisis engulfing the entire industry.

While Steward’s for-profit ownership structure put its hospitals at a disadvantage, many health care executives say the state’s entire network of hospitals is approaching a capacity shortage not seen since the early days of the Covid-19 pandemic.

Industry leaders are calling for urgent action from the Healey administration and the Legislature to help stem the crisis. Even just simplifying the state regulatory bureaucracy and approvals for bringing uninsured patients into the MassHealth system would help, executives say.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： A new drug could help frostbite victims avoid its ravages

WSS

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

New CMS data security rules will hurt Medicare, Medicaid research

How to make the FDA’s new prescription one

Popular nasal decongestant doesn't actually relieve congestion

As AI regulations shape up, health tech startups beg for clarity

Measles policy set amid Florida outbreak alarms vaccine proponents

hotspot

explore

leisure time

Hollywood unions extend contract negotiations for actors

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

State Dept. review finds Biden bears some blame for Afghanistan failures

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Medical records are filled with copy

Diverse clinical trials: Why aren’t we there yet?

Hepatitis C has a cure — but many Americans still lack access to it

Popular nasal decongestant doesn't actually relieve congestion

Peter Hotez and the public health issue of online harassment

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Wikipedia

Will the IRA bring competition to the biologics market?

What to make of Biden’s latest efforts on cancer research

Hospitals are piloting generative AI tools as regulators play catch

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Pig kidney works a record two months in donated body

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

hotspot

knowledge

hotspot

hotspot